ProCE Banner Activity

MM16: Update on Durability of Adaptive Immune Responses to SARS-CoV-2

Multimedia
In this presentation, Professor Sharon Lewin discusses the recent data on the durability of antibody and T cell responses to SARS-CoV-2 and the implications for reinfection.

Released: September 04, 2020

Expiration: September 03, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grant provided by

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Sharon R. Lewin, AO, FRACP, PhD, FAA, FAHMS

Director, Doherty Institute
Melbourne Laureate Professor
Director, Cumming Global Centre for Pandemic Therapeutics
Head, Department of Infectious Diseases
The University of Melbourne
Melbourne, Australia

Sharon Lewin, AO, FRACP, PhD, FAAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.